Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review

Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review

Aim: We conducted a chart review to investigate the detailed outcomes of patients with schizophrenia who discontinued long-acting injectable second-generation antipsychotic (LAI-SGA) therapy due to adverse events (AEs). Methods: The study included patients with schizophrenia and related psychotic di...

Full description

Bibliographic Details
Main Authors: Hatano, M. (Author), Iwata, N. (Author), Kishi, T. (Author), Okuya, M. (Author), Sakuma, K. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
adult
adverse events
akathisia
Antipsychotic Agents
aripiprazole
Aripiprazole
Article
body weight gain
cholinergic receptor blocking agent
controlled study
delayed release formulation
Delayed-Action Preparations
drug withdrawal
extrapyramidal symptom
fatigue
female
health survey
hospitalization
human
Humans
hyperprolactinemia
injection site pain
long-acting injectable second-generation antipsychotic
major clinical study
male
medical record review
neuroleptic agent
paliperidone
Paliperidone Palmitate
psychopharmacotherapy
psychosis
rhabdomyolysis
risperidone
sample size
schizophrenia
Schizophrenia
side effect
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items